Criminal case
United States v. Purdue (OxyContin misbranding)
- Authority
- US District Court for the Western District of Virginia
- Case number
- Not confirmed in the records read
- Filed or opened
- 2007
- Organization
- Purdue Pharma L.P.
- Current stage
- Guilty plea and court proceeding of 20 July 2007, as described by the US AttorneyS1.
- Outcome
- Guilty plea. Final.
Decisions and steps
- Felony misbranding plea by the company, with US$600 million in fines, forfeitures and civil recoveriesS1
Claims this case bears on
- Contradicted88Purdue's original OxyContin label said that delayed absorption from OxyContin tablets was believed to reduce the drug's abuse liability.Official report, 31 July 20074 records citedProduct claims
Sources
- S1Tier A Testimony of The Honorable John L. BrownleeUS Senate Committee on the Judiciary (testimony of the US Attorney for the Western District of Virginia). Government press release. 31 July 2007.Prosecutor's sworn account of the 2007 plea, the label wording and the falsity of the marketing claims. It is not the plea agreement itself.